GlassScriptPhysician profile
Cheryl Motter
NPI 1073034427
$719.16
in general payments reported to CMS, 2019-2025
17 companies · $60.30 in 2025
The $60.30 reported for 2025 was less than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $392 · 2022: $59.77 · 2023: $67.61 · 2024: $139 · 2025: $60.30.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $267.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $267.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $186.61 | 2022-2025 | Comet, Avvigo Guidance System, Lux-Dx Insertable Cardiac Monitor |
| Janssen Pharmaceuticals, INC | $114.36 | 2021 | |
| Astellas Pharma US INC | $90.07 | 2021 | |
| Abiomed | $69.24 | 2024 | Impella |
| Merck Sharp & Dohme LLC | $49.73 | 2021-2024 | Verquvo |
| Abbott Laboratories | $32.65 | 2021 | |
| W. L. Gore & Associates, INC. | $28.87 | 2025 | Gore Cardioform Septal Occluder |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $24.36 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $18.28 | 2021 | |
| Esperion Therapeutics, INC. | $16.44 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $15.52 | 2024 | Farxiga |
| Bayer Healthcare Pharmaceuticals INC. | $13.22 | 2021 | |
| Teleflex LLC | $13.18 | 2023 | Vascband |
| Actelion Pharmaceuticals US, INC. | $11.99 | 2021 | |
| Amgen INC. | $11.74 | 2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $11.51 | 2021 | |
| Pfizer INC. | $11.39 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cheryl Motter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.